Slide 1: ASX correction letter on typographical errors
For personal use only Clover Corporation Limited 1st Floor, 160 Pitt Street ABN 85 003 622 866 SYDNEY. N.S.W. 2000 Telephone + 61 2 9232 7166 Facsimile + 61 2 9233 1025 5 May 2009 Australian Stock Exchange (Sydney) Limited Attention: Companies Department BY ELECTRONIC LODGEMENT Dear Sir/Madam We wis
Slide 2: Investor Briefing May 2009
For personal use only Investor Briefing May 2009
Slide 3: Disclaimer
For personal use only DISCLAIMER The release, publication or distribution of this presentation in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this presentation is released, published or distributed should inform themselves about and observe s
Slide 4: Introduction
For personal use only INTRODUCTION Clover Corporation provides nutritional and functional ingredients for use in foods and specialty applications using proprietary technology. The current primary activities of the company are involved with the provision of HiDHA® omega-3 fish oils/powders and debitt
Slide 5: Company Overview
For personal use only COMPANY OVERVIEW • Mission is to identify, develop and commercialise specialty functional and nutritional ingredients with an initial focus on HiDHA® marine oils. • Clover Corporation was founded in 1988 and listed on the ASX in 1999. • Nu-Mega Ingredients was founded as a JV i
Slide 6: Summary of Financial Performance FY08
SUMMARY OF FINANCIAL For personal use only PERFORMANCE FY08 FY2008 FY2007 Shares on issue 165.18 million 165.18 million Total contributed equity $32.92 million $32.92 million Market capitalization $35.51 million $17.34 million (# 21.5c/s) Cash total $10.759 million $10.960 million Sales Revenue $21.
Slide 7: Summary of Financial Performance FY08
SUMMARY OF FINANCIAL For personal use only PERFORMANCE FY08 FY2008 FY2007 EBITDA $2.272 million $537,000 Profit $4.135 million $635,000 EPS 2.5 cents/share 0.38 cents/share Major shareholder WHSP & Co. Ltd (28.55%) WHSP & Co. Ltd (28.55%) Top 20 shareholders 59.75% of shares 55.1% of shares 6 As per
Slide 8: FY08 Key Milestones
For personal use only FY08 KEY MILESTONES • Improvements and increased production capacity at the Altona oil refinery. • Commercial launch of new ThermoMAX™ encapsulation technology developed in conjunction with Food Science Australia/CSIRO. • Secured 5 year supply contract with Mead Johnston & Comp
Slide 9: Historical Financial Performance
HISTORICAL FINANCIAL For personal use only PERFORMANCE million ($) 5 4 3 2 1 0 FY06 FY07 FY08 Net Profit Tax Credit 8
Slide 10: Summary Interim Results Clover 1H09
Summary Interim Results For personal use only Clover 1H09 HY’09 HY’08 Variance (%) Revenue $9.603M $9.989M Down3.9% EBIT $2.064M $1.169M Up 76% NPAT $1.609M $0.685M Up 134%
Slide 11: Clinical Research
For personal use only CLINICAL RESEARCH 10
Slide 12: Publications
For personal use only PUBLICATIONS 11
Slide 13: Priorities for FY09
For personal use only PRIORITIES FOR FY09 • Consolidate improved sales in infant formula applications. – Improve the product mix. • Expand sales & distribution network. • Increase opportunities in food applications. • Selectively recruit for growth. • Move FFI to profitability • Continue development
Slide 14: New Clover Website
For personal use only NEW CLOVER WEBSITE 13
Slide 15: For personal use only
For personal use only 14
Slide 16: Nu-Mega Ingredients Pty Ltd Overview
For personal use only NU-MEGA INGREDIENTS PTY LTD Overview • Primary interest in the provision of HiDHA omega-3 tuna oils/powders. • Refine crude tuna oil. • Prepare high quality oils & powders. • Utilise proprietary/patented encapsulation technologies for a range of nutritional oils and other bioac
Slide 17: Nu-Mega Sales & Distribution Network
NU-MEGA SALES & DISTRIBUTION For personal use only NETWORK SALES OFFICE MANUFACTURING SITE AGENTS 16
Slide 18: Where Does Nu-Mega Sell Its Ingredients?
WHERE DOES NU-MEGA SELL For personal use only ITS INGREDIENTS? Australia/New Zealand 39% Asia 52% Europe 8% USA 1% Infant formula Food Supplement Animal feed AGM, November 2008 17
Slide 19: Nu-Mega Priorities in FY09
For personal use only NU-MEGA INGREDIENTS PTY LTD Priorities in FY09 • Increase sales in value added applications. • Increase sales & marketing presence. • Improve oil quality & increase capacity. • Finalise integration of Nu-Mega into Clover Corporation. • Expand technology & new product developmen
Slide 20: Nu-Mega Challenges
For personal use only NU-MEGA INGREDIENTS PTY LTD Challenges • Uncertain market conditions. – Customers – Exchange rates • Customers are reviewing ordering patterns. • Regional regulatory issues; – Indonesia – Europe. • Successfully expand sales through GTC Nutrition. 19
Slide 21: Future Food Ingredients
For personal use only Future Food Ingredients 20
Slide 22: Future Food Ingredients Overview
For personal use only FUTURE FOOD INGREDIENTS Overview • Manufacturing facility located in Moree, NSW. – Plant commissioned in December 2005. – CEO Warren Hannam – Plant Manager, QA & Production staff. • Nu-Soya technology exclusively licensed worldwide from Byron Australia. – Preparation of soy ing
Slide 23: Future Food Ingredients Product Range
For personal use only FUTURE FOOD INGREDIENTS Product Range • Range of Enzyme Active Soy ingredients – Flours, Grits, Splits & Flakes • Range of Nu- Soya™ ingredients – Using a propriety process to produce whole bean, bland flavoured Soy Ingredients – Flours, Grits, Flakes & Toasted Flakes • Certifi
Slide 24: FFI Financial Performance
FFI FINANCIAL PERFORMANCE For personal use only 1H09 – Sales revenue million ($) 2 1.6 1.2 0.8 0.4 0 1H08 1H09 Sales Revenue 23
Slide 25: Future Food Ingredients Focus during FY09
For personal use only FUTURE FOOD INGREDIENTS Focus during FY09 • Continue to increase Nu-Soya™ sales, particularly in Asia. • Increase product range to maximize utilization of the plant. • Identify specialty nutritional &/or functional applications. • Develop opportunity in Asia for specialized org
Slide 26: Outlook for FY09
For personal use only CLOVER CORPORATION Outlook for FY09 • Challenging period in an unsettled business environment. • Modest sales increase anticipated in FY09. • Control expenditure. • Address changes in regulations in Indonesia & Europe. • Expand the distribution and sales network in the America’
Slide 27: Thank You
For personal use only THANK YOU Questions? 26